1. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
2. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy
   Huaji Jiang et al, 2024, Autophagy CrossRef
3. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
   Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
4. Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
   Jian Sun et al, 2024, Drug Design, Development and Therapy CrossRef
5. A Link Between Chemical Structure and Biological Activity in Triterpenoids
   Cunqin Wang et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
6. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
7. The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases
   Zhenglin He et al, 2023, Frontiers in Pharmacology CrossRef
8. Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer
   Karen Yamaguchi et al, 2022, Biomolecules CrossRef
9. Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
   Chao Chen et al, 2022, Nano Convergence CrossRef
10. Neuroplasticity to autophagy cross-talk in a therapeutic effect of physical exercises and irisin in ADHD
    Alhasan Abdulghani et al, 2023, Frontiers in Molecular Neuroscience CrossRef
11. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
12. Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells
    Yujuan Zhan et al, 2023, Cell Biology and Toxicology CrossRef
13. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
14. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
    Bartosz Mateusz Gąsiorkiewicz et al, 2021, Investigational New Drugs CrossRef